menu Search
Zuellig Pharma
Daiichi Sankyo Thailand

DAIICHI SANKYO EUROPE GMBH

Featured products of Daiichi Sankyo Europe GmbH
Nexletol
Nexletol FC tab 180 mg
bempedoic acid
Packing/Price
30's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX15 - bempedoic acid : Belongs to the class of other lipid modifying agents.
Nexlizet
Nexlizet FC tab
ezetimibe, bempedoic acid
Packing/Price
30's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10BA10 - bempedoic acid and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
Distributed by Zuellig Pharma
Nexletol
Nexletol FC tab 180 mg
bempedoic acid
Packing/Price
30's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX15 - bempedoic acid : Belongs to the class of other lipid modifying agents.
Nexlizet
Nexlizet FC tab
ezetimibe, bempedoic acid
Packing/Price
30's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10BA10 - bempedoic acid and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
Marketed by Daiichi Sankyo Thailand
Nexletol
Nexletol FC tab 180 mg
bempedoic acid
Packing/Price
30's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX15 - bempedoic acid : Belongs to the class of other lipid modifying agents.
Nexlizet
Nexlizet FC tab
ezetimibe, bempedoic acid
Packing/Price
30's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10BA10 - bempedoic acid and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.